1 therapeutic(s) match your criteria. Click on the therapeutic name to open a summary page.
[NFD = No Further Development, (w) = Withdrawn, Semicolons delimit separate variable domains for bispecifics]
Click a column heading to sort by that attribute (may take a couple of seconds if the table contains many entries)
Therapeutic | Format | Highest Clinical Trial (Feb '25) | Est. Status (Feb '25) | Target | Year Proposed | 100% SI Struc. | 99% SI Struc. | 95-98% SI Struc. |
---|---|---|---|---|---|---|---|---|
coltuximab | Whole mAb ADC | Phase-II | Active | CD19 | 2013 | YES | no | no |
Thera-SAbDab tracks all WHO-recognised antibody- and singe-domain antibody-derived therapeutics with released sequences.
Download a spreadsheet of all therapeutic sequences/structures (last list - PL132): xlsx / csv
If you believe we have missed a WHO-recognised therapeutic with a public sequence, please contact us at opig <~at~> stats.ox.ac.uk
Schneider, C., Raybould, M.I.J., Deane, C.M. (2022) SAbDab in the Age of Biotherapeutics: Updates including SAbDab-Nano, the Nanobody Structure Tracker. Nucleic Acids Res. 50(D1):D1368-D1372 [link]
SAbDab paper: Dunbar, J., Krawczyk, K. et al (2014). Nucleic Acids Res. 42. D1140-D1146 [link]
Thera-SAbDab paper: Raybould, M.I.J., Marks, C. et al (2019). Nucleic Acids Res. gkz827 [link]